Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of toxic epidermal necrolysis.

Expert opinion on pharmacotherapy - 1 Sept 2010

Lee Ming Ta Michael, Hung Shuen-Iu, Wei Chun-Yu, Chen Yuan-Tsong

Abstract excerpt

IMPORTANCE OF THE FIELD: Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are two of the most severe drug-induced cutaneous reactions. Advances in genome technologies have allowed researchers to identify genetic markers associated with this drug-associated event and these have provided a potential tool for prevention. AREAS COVERED IN THIS REVIEW: Current updates of genetic biomarkers that have...

Topics

Join the communities discussing this publication.

Drug-Related Side Effects and Adverse Reactions
Gene Frequency
Genes, MHC Class I
Genetic Markers
Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Stevens-Johnson Syndrome

Source

Identifiers

PMID: 20536296
DOI: 10.1517/14656566.2010.495120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of toxic epidermal necrolysis.PMID 20536296Read ↗

Pharmacogenetics of cutaneous adverse drug reactionsSemantic proximity Read ↗

HLA-B Genotyping to Detect Carbamazepine-Induced Stevens-Johnson Syndrome: Implications for Personalizing MedicineSemantic proximity Read ↗

Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction.Semantic proximity Read ↗

Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in EuropeSemantic proximity Read ↗

A Recent Update of Pharmacogenomics in Drug-induced Severe Skin ReactionsSemantic proximity Read ↗

Genetic predisposition of life-threatening antiepileptic-induced skin reactions.Semantic proximity Read ↗

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.Semantic proximity Read ↗

Toxic epidermal necrolysis: the year in review.Semantic proximity Read ↗

Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.Semantic proximity Read ↗

Relationship Between the<i>HLA-B*1502</i>Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisSemantic proximity Read ↗

Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via PharmacogenomicsSemantic proximity Read ↗

Human leukocyte antigens and drug hypersensitivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.